A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2021; you can also visit the original URL.
The file type is
Background: Multiple studies reporting that down-regulation of SOCS6 plays vital roles in promoting progression of many tumors have been published. The present study was performed to identify whether SOCS6 was an biomarker significantly associated with prognosis of patients diagnosed with gastrointestinal stromal tumor (GIST). Methods: Immunohistochemical staining was accomplished to evaluate the expression levels of SOCS6 among GIST patients. The impacts of SOCS6 expression on overall survivaldoi:10.21203/rs.3.rs-414295/v1 fatcat:bcfctgu3vvbqhgs5udd7tvgom4